Total Payments
$1,273
2024 Payments
$82.06
Companies
15
Transactions
52
Payment Breakdown by Category
Food & Beverage$1,273 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,273 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $453.48 | 4 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $221.94 | 21 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $139.58 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $137.12 | 2 | $0 (2021) |
| ABBVIE INC. | $78.60 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $58.91 | 5 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $37.58 | 2 | $0 (2023) |
| Smith+Nephew, Inc. | $33.61 | 1 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $33.43 | 2 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $15.64 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82.06 | 5 | Novartis Pharmaceuticals Corporation ($47.33) |
| 2023 | $71.01 | 4 | Otsuka America Pharmaceutical, Inc. ($37.58) |
| 2022 | $79.46 | 4 | Smith+Nephew, Inc. ($33.61) |
| 2021 | $52.69 | 4 | AbbVie Inc. ($27.26) |
| 2020 | $124.46 | 1 | Novo Nordisk Inc ($124.46) |
| 2019 | $425.97 | 11 | Novo Nordisk Inc ($205.02) |
| 2018 | $244.31 | 12 | Novo Nordisk Inc ($124.00) |
| 2017 | $192.93 | 11 | Novartis Pharmaceuticals Corporation ($92.25) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: ANTIBIOTIC | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/03/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: PSYCHIATRY | ||||||
| 08/08/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Central Nervous System | ||||||
| 06/05/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Central Nervous System | ||||||
| 11/02/2022 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/18/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Pain Management | ||||||
| 02/09/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/04/2022 | Smith+Nephew, Inc. | RENASYS GO v2 HOME (Device) | Food and Beverage | In-kind items and services | $33.61 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 09/14/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/23/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/21/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/13/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: UROLOGY | ||||||
| 03/03/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.46 | General |
| Category: Diabetes | ||||||
| 12/10/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: CNS | ||||||
| 11/12/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/04/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $90.70 | General |
| Category: Diabetes | ||||||
About Dr. James Warrington, D.O
Dr. James Warrington, D.O is a Family Medicine healthcare provider based in Cleveland, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912919234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Warrington, D.O has received a total of $1,273 in payments from pharmaceutical and medical device companies, with $82.06 received in 2024. These payments were reported across 52 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,273).
Ad
Practice Information
- Specialty Family Medicine
- Location Cleveland, MS
- Active Since 08/13/2006
- Last Updated 12/09/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1912919234
Products in Payments
- Ozempic (Drug) $339.16
- FARXIGA (Drug) $137.12
- Xultophy 100/3.6 (Drug) $114.32
- ENTRESTO (Drug) $92.25
- APTIOM (Drug) $86.00
- LATUDA (Drug) $74.04
- LONHALA MAGNAIR (Drug) $61.90
- LEQVIO (Drug) $47.33
- DALVANCE (Drug) $43.90
- REXULTI (Drug) $37.58
- ANORO (Drug) $35.69
- TEFLARO (Drug) $34.70
- RENASYS GO v2 HOME (Device) $33.61
- Austedo XR (Drug) $33.43
- TRELEGY ELLIPTA (Drug) $23.22
- Seglentis (Drug) $15.64
- NUZYRA (Drug) $13.60
- PREVNAR - 13 (Biological) $12.88
- MYRBETRIQ (Drug) $12.76
- GENERAL - THERAPIES (Device) $12.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cleveland
Dominic King, D.o, D.O
Family Medicine — Payments: $337,674
Family Medicine $337,674
Jeannette Potts, Md, MD
Family Medicine — Payments: $30,044
Family Medicine $30,044
Meaghan Combs, Md, MD
Family Medicine — Payments: $25,727
Family Medicine $25,727
George Stokes, Md, MD
Family Medicine — Payments: $18,678
Family Medicine $18,678
Dr. Charles Brock, M.d, M.D
Family Medicine — Payments: $9,519
Family Medicine $9,519
Mr. Cecil Breetzke, Md, MD
Family Medicine — Payments: $9,499
Family Medicine $9,499